Quince Therapeutics (QNCX) Approves Reverse Stock Split—SEC 8-K Filing Details (June 11, 2026)
Quince Therapeutics, Inc. (QNCX) Announces Results of 2026 A...
Sign in to continue:
Quince Therapeutics, Inc. (QNCX) Announces Results of 2026 A...
Intuit Inc. Announces \$1.75 Billion Senior Notes Offering ...
Long Table Growth Corp. Issues Balance Sheet and Financial S...
Seritage Growth Properties (NYSE: SRG) Announces Results of ...
Redwood Trust Announces Q2 2026 Dividends: Key Investor Insi...
WSFS Financial Corporation Issues Regulation FD Disclosure o...
Fractyl Health, Inc. Announces Results of 2026 Annual Meetin...
StageWise Strategies Corp. - Change of Control and Board Res...
Light & Wonder, Inc. Announces Results of 2026 Annual Stockh...
Laser Photonics (LASE) Q1 2026 Results: Defense Win, Capital...